Program Manager II - Program Management
Catalent Pharma Solutions
Summary
This role is responsible for delivering assigned program objectives within agreed time, budget, scope, and quality. The position involves managing cross-functional, multi-site project teams and maintaining open, solution-focused communication with clients. The successful candidate will monitor progress, ensure high-quality deliverables, and drive program success through collaboration and leadership.
Job description
Minimum Requirements
- Bachelor of Science in Science or Engineering, or equivalent combination of education and experience required. Advanced degree (Master of Science, Master of Business Administration, Doctor of Philosophy) is preferred.
- Approximately 5+ years of direct experience in project management and/or the pharmaceutical industry.
- Project Management Professional or Project Management certification or coursework preferred.
- Working knowledge of biologics fermentation, cell culture, purification, and analytics preferred.
- Professional experience in a related field such as biologics, biotechnology, or pharmaceuticals preferred.
Requirements
- Bachelor of Science in Science or Engineering, or equivalent combination of education and experience required.
- Approximately 5+ years of direct experience in project management and/or the pharmaceutical industry.
- Project Management Professional or Project Management certification or coursework preferred.
- Working knowledge of biologics fermentation, cell culture, purification, and analytics preferred.
- Professional experience in a related field such as biologics, biotechnology, or pharmaceuticals preferred.
Benefits
- Paid time off
- 8 paid holidays
- Medical, dental & vision
- Tuition reimbursement
- Career development
- Annual performance reviews
Company overview
Catalent Pharma Solutions, now known as Catalent, Inc., is a leading global contract development and manufacturing organization (CDMO) headquartered in Tampa, Florida. Founded in 2007 as a spin-off from Cardinal Health's pharmaceutical technologies segment, the company has grown into a major player in the pharmaceutical services industry. Catalent provides comprehensive drug development and manufacturing solutions including drug delivery technologies, formulation development, analytical testing, clinical and commercial manufacturing, clinical packaging, and supply chain services. The company operates over 50 facilities across four continents and has supported more than half of all FDA-approved products over the past decade. With approximately 16,900 employees, Catalent produces over 70 billion doses annually for more than 8,000 products, serving major pharmaceutical companies like Pfizer, Moderna, Novo Nordisk, and Bristol-Myers Squibb. In 2024, the company was acquired by Novo Holdings A/S for $16.5 billion, further strengthening its position in the global pharmaceutical manufacturing landscape.